Versant partners gear up for a $700M bonanza of biotech bets, with a special focus all their own

Versant partners gear up for a $700M bonanza of biotech bets, with a special focus all their own

Source: 
Endpoints
snippet: 

In a global biotech industry where venture investors carve own familiar strategy, Versant Ventures has always preferred to go its own way. Versant partners often go off the beaten track to find their startups. They’ll go it alone at the launch point sometimes, or in syndicates. And they have fired up a group of discovery lab operations around the world to help seed the ground with their new biotech creations.